COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 3181: Articles 31801-31810  | Next

Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model
Shao, P., Shan, Y.
10.1101/2020.01.28.923169 — Posted: 2020-01-28
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., Ying, T.
10.1101/2020.01.28.923011 — Posted: 2020-01-28 Discussion: Onsite
Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., Zhu, W.
10.1101/2020.01.27.921627 — Posted: 2020-01-28 Discussion: Onsite | Offsite
Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease
Lodge, E. K., Schatz, A. M., Drake, J. M.
10.1101/2020.01.27.921536 — Posted: 2020-01-28
Breaking down of the healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China
Ming, W.-k., Huang, J., Zhang, C. J. P.
10.1101/2020.01.27.922443 — Posted: 2020-01-28 Discussion: Onsite
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
Paraskevis, D., Kostaki, E. G., Magiorkinis, G., Panayiotakopoulos, G., Tsiodras, S.
10.1101/2020.01.26.920249 — Posted: 2020-01-27 Discussion: Onsite
Origin time and epidemic dynamics of the 2019 novel coronavirus
Zhang, C., Wang, M.
10.1101/2020.01.25.919688 — Posted: 2020-01-26 Discussion: Onsite
Transmission dynamics of 2019 novel coronavirus (2019-nCoV)
Liu, T., Hu, J., Kang, M., Lin, L., Zhong, H., Xiao, J., He, G., Song, T., Huang, Q., Rong, Z., Deng, A., Zeng, W., Tan, X., Zeng, S., Zhu, Z., Li, J., Wan, D., Lu, J., Deng, H., He, J., Ma, W.
10.1101/2020.01.25.919787 — Posted: 2020-01-26 Discussion: Onsite
Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., Zuo, W.
10.1101/2020.01.26.919985 — Posted: 2020-01-26 Discussion: Onsite
Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Hu, Y., Song, Z.-G., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., Zhang, Y.-Z.
10.1101/2020.01.24.919183 — Posted: 2020-01-25 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).